Huabang Pharmaceutical

Chongqing Huabang Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and manufacturing of dermatological and anti-tuberculosis medications. As a core subsidiary of the publicly traded Huabang Health, the company maintains a dominant market share in China's dermatology sector with a broad portfolio of products treating acne, psoriasis, and various forms of dermatitis. Beyond its leadership in skin health, Huabang is a major provider of anti-infectives, particularly for the treatment of tuberculosis, and has expanded into oncology and respiratory therapeutics. The company operates multiple high-standard GMP-certified manufacturing facilities and maintains a robust vertically integrated supply chain for active pharmaceutical ingredients (APIs). Huabang Pharmaceutical is recognized for its strong commercial presence in China and its growing focus on international regulatory compliance for global market expansion.